FIRM FIXED PRICESMALL BUSINESS SET ASIDE - PARTIAL
GENSCRIPT USA INC - MONOCLONAL ANTIBODY PRODUCTION
PIID: 75F40120P00404
Signed Date: Jan 26, 2026Effective Date: Jul 21, 2020End Date: Closed on Jul 31, 2021
Key Details
Description
MONOCLONAL ANTIBODY PRODUCTION
Contractor Information
Similar Awards
DEVELOPMENT AND DOMESTIC MANUFACTURE OF ADJUVANTED, PANDEMIC INFLUENZA VACCINES
SANOFI VACCINES US INC.
$612.2M
OTHER TRANSACTION: PRODUCTION OF DRUG SUBSTANCES AND DRUG PRODUCTS AT COMMERCIAL SCALE UNDER BIOMAP-CONSORTIUM
ADVANCED TECHNOLOGY INTERNATIONAL
$304.0M
EXPANSION OF PRODUCTION CAPACITY OF MAN-MADE FABRIC FOR MANUFACTURING DISPOSABLE MEDICAL GOWNS
ADVANCED TECHNOLOGY INTERNATIONAL
$248.5M
OTHER TRANSACTION: PROCUREMENT AND SUSTAINMENT OF N95 MASK MANUFACTURING CAPACITY UNDER THE BIOMAP-CONSORTIUM.
ADVANCED TECHNOLOGY INTERNATIONAL
$141.3M
EXPANSION OF DOMESTIC MANUFACTURING CAPACITY FOR NITRILE GLOVES
ADVANCED TECHNOLOGY INTERNATIONAL
$61.0M
Stay Updated
Get notified about new opportunities matching your interests.